Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial

Peer review reports

Original Submission
16 Nov 2016	Submitted	Original manuscript
1 Jan 2017	Reviewed	Reviewer Report - Gianfranco Di Gennaro
23 Jan 2017	Reviewed	Reviewer Report - Franco Schiavon
19 Feb 2017	Author responded	Author comments - Rona Smith
Resubmission - Version 2
19 Feb 2017	Submitted	Manuscript version 2
Publishing
20 Feb 2017	Editorially accepted
7 Mar 2017	Article published	10.1186/s13063-017-1857-z

Back to article page